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842-5 Fractional Flow Reserve of the Infarct-Related Artery 
Early After Myocardial Infarction Identifies Reversibility 
on Dipyridamole Sestamibi Single-Photon Emission 
Computed Tomography Perfusion Imaging 
Kurt G. Bamnahaus, Gregory G. Bishop, Michael Rag&a. Denny D. Watson, James 
Garnett. Lawrence W. Gimole. Ian J. Sarembock. Georae A. Belier. Eric R. Powers. 
Habib Samady, University of Virginia Health System, Charlottesville, VA 
Introduction: Fractional flow reserve (FFR) is an invasive physiologic index of lesion 
severity shown to correlate with reversibility on stress perfusion imaging late after myo- 
cardial infarction (FFR i 0.78). The FFR cutoff of < 0.78 has not been validated ear& (3- 
4 days) after myocardial infarction (MI), a time when patients frequently undergo corn-- 
nary angiography. Accordingly, we hypotheszed that an FFR 5 0.78 of the infarct-related 
artery ear/y after Ml identifies reversible defects on Dipyridamole Tc-99m Sestamibi 
SPECT myocardial perfusion imaging (DP-MPI). 
Methods: Thirty-two stable patients, 3.7-tl.6 days after acute MI, underwent DP-MPI fol- 
lowed by FFR measurement of their infarct related arteries. Coronary angiography and 
ventriculography were used to identify and match the infarct zone to the DP-MPI seg- 
ments. The DP-MPI (14 segmentsfpt) were read blindly as showing reversible (21 revers- 
able segment in the infarct zone) 01 fixed defects. 
Results: Mean age was 57+12 yrs, mean LVEF was 54*9%, and 71% had ST elevation 
Ml (peak troponin 1=85*83). Mean.percent diameter stenosis (‘%DS) was 74*14%, and 
mean FFR was 0.66eO.17. Eighteen patients had reversible defects, and 14 patients had 
fixed defects on DP-MPI. Mean FFR was significantly lower in the reversible group than 
in the fixed group (0.61*0.14 vs. 0.73iO.19, p&05). Sixteen of 18 patients with ravers- 
ible defects on DP-MPI had FFRi 0.78, yielding a sensitivity of 89%. Among patients 
with fixed defects, 7/14 (50%) also had FFRb 0.78. These 7 patients with fixed defects 
had severe angiographic stenoses (%DS=81&6) with low FFR (0.57+0.12). 
Conclusion: A fractional flow reserve (FFR) of< 0.78 in the infarct related artery, mea- 
sured 3-4 days post-MI, Identifies reversibility in the infarct zone as assessed by dipy- 
ridamole SPECT MPI with high sensitivity An FFR a.78 may also be seen in 
association with fixed defects in the presence of severe infarct related artery stenosis. 
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842-6 Coronary Wedge Pressure During Percutaneous 
Coronary Intervention Can Predict Late Lefi Ventricular 
Remodeling After Reperfusion in Patients With Acute 
Anterior Myocardial Infarction 
Koichi Tamita Takashi Akasaka, Atsushi Yamamuro, Tsutomu Takagi, Kazuaki Tanabe, 
Kunihiko Nagat, Tomoko Tani, Kenji Yamabe. Mlnako Katayama, Motoaki Ibukl, 
Shigefuml Morioka. Kobe General Hospital, Kobe. Japan, Kawasaki Medical College, 
Kurashiki, Japan 
Background: Recent studk?s have reported that coronary wedge pressure (CWP) 
assessed by pressure guidewire reflects the degree of microvascular damage in patients 
with anterior acute myocardial infarction (AMI), especially in patients with no-reflow phe- 
nomenon. However, the relation between left ventricular (LV) remodeling and CWP dur- 
ing percutaneOus coronary intervention (PCI) has not yet been investigated. We 
assessed the hypothesis that CWP assessed during PCI can predict progressive LV 
remodeling in patients with anterior AMI. 
Methods: The study population consisted of 34 patients with a first anterior AMI treated 
with primary coronary stenting. The CWP was defined as distal coronary pressure 
assessed by pressure guidewire during the balloon occlusion. The CWPI aorta pressure 
(Pa) was determined by simultaneous measurement of mean Pa and CWP. The left ven- 
triculograms at the baseline and 6 months after AMI were analyzed to measure LV vol- 
urns. Late LV remodeling was defined as an increase in end-diastolic volume index > 
20%. 
Results Fifteen patients of 34 pattents showed late LV remodeling. The CWP and CWP/ 
Pa demonstrated good positive correlations with changes in LV end-diastolic volume 
index (rz0.48, p=O.Ol; rz0.52, p=O.Ol, respectively). The optimal cutoff value to predict 
LV remodeling was 27 mmHg for CWP and 0.23 for CWPlPa (sensitivity=83%, specific- 
ity=77% and sensitivity=79%, specificity=80%, respectively). 
Conclusion: These data suggest that the assessment of CWP during PCI provides an 
accurate mean of predicting late LV remodeling in patients with anterior AMI. 
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1174-187 Incidence and Outcomes of Heparin-Induced 
Thrombocytopenia Following Acute Coronary 
Syndromes 
Liviu T. Klein, Oana L. Klein, Grzegorz P. Rozmus. Juan Chediak, Advocate Illinois 
Masonic Medical Center, Chicago, IL 
Background: Patients (pts.) with acute coronary syndromes are treated with unfraction- 
ated (UH) or low molecular weight hepartn (LMWH). One of the side effects of heparin 
therapy is heparin - induced thrombocytopenia with/without thrombosis (HITT/HIT). The 
purpose of our study was to evaluate the incidence and outcomes of HlT/HlTT in this set- 
tmg. since they are not very well defined. 
Methods: We reviewed the charts of 634 consecutive pts. admitted in our institution with 
a diagnosis of acute coronary syndrome. An immunoassay ELISA was used to detect 
anti - heparinJPF4 antibodies. HIT was defined as a drop in the platelet count of more 
than 50% of baseline and a positive ELISA test. HlTr was defined as HIT plus clinical or. 
ultrasound evidence of arterial and/or venous thrombosis. 
Results: 9 (4.39%) of 205 UH treated pts. and 6 (1.39%) of 429 LMWH treated pts. 
developed HIT/HITT. Thrombocflopenia became apparent after 7.86 days and the diag- 
nosis was made after 11.2 days of heparln exposure. Thrombocytopenia developed 
more rapidly (7 vs. 9.16 days, p = 0.045) and the diagnosis was made earlier (10.11 vs. 
12.83 days, p = 0.039) in UH treated pts. The mean baseline platelet count was 169 x 
1 Os/pl. The platelet count at diagnosis was 61 x 1 OS/f& being significantly lower in UH 
treated pts. (52.55 x lO’/f~ vs. 73 x lO?pl, p = 0.039). At diagnosis, 3 pts. (20%) had 
HITT and 12 (80%) had HIT. Heparin was discontinued in all pts., the 3 Hln and 2 of 
HIT pts. were treated with the direct thrombin inhibitor Argatroban? 2 of the 10 untreated 
HIT pts. progressed to HllT and treatment with Argatroban” was initiated. The platelet 
count recovered in all pts. after an average of 4.4 days. Conclusion: In our study, the fre- 
quency of HIT/HITT in the setting of an acute coronary syndrome was estimated at 
2.36%. Thrombocytopenia developed earlier, was more common and more pronounced 
in UH treated pts. However, in both groups the diagnosis of HIT/HITT was delayed by a 
mean of 3 days. In our study, 20% of the untreated HIT pts. progressed to HITT. These 
results support the need for a prompt and earlier recognition of HIT/HITT and possible 
treatment of all pts. with direct thrombin inhibitors to prevent the development of HITT. 
1174-188 Oral N-Acetylcysteine Administered Immediately Prior 
to Routine Percutaneous Coronary Procedures 
Ameliorates Contrast-Induced Nephrotoxicity 
Gustav0 J. Noaareda, Donald R. Ricci, Ian M. Penn, Victor Huckell, Rebeca Fox, Jackie 
Chow, Anne Eichman, Christopher E. Buller, Vancouver General Hospital, Vancouver, 
BC, Canada 
Background: Pre-treatment (24hour) with the antioxident N-acetylcysteine (NAC) 
before percutaneous coronary procedures (PCP) in patients with chronic kidney dysfunc- 
tion is shown to attenuate contrast induced nephrotoxlcity (GIN). However. 24 hour pre- 
treatment with NAC IS often not feasible. We aimed to explore possible benefits of admin- 
istering oral NAC immediately prior to PCPs among pts participating in a renal artety 
stenosis screening study coincident with PCP with protocol driven paired kidney function 
testing. 
Methods pts with ECC ~50 mlimin were prospectively identified and those not receiving 
conventional pre-treatment nor enrolled in NAC clinical trials were candidates for empiric 
pre-procedure NAC (oral 600mg immediately prior to PCP and contined at 600mg BID for 
48h or discharge if &slier) at their physicians discretion. CIN was pre-defined as a rise in 
creatinine of > 44pmol/L 7 day post compared to baseline. 
Results Treatment groups were similar with regard to known determinants of GIN, dia- 
betes, hypertension ,age and gender. In the control pts 8 had CIN of which 1 required 
transient hemodialysis and 1 died. Kidney dysfunction persisted in 6 of 8 pts at 1 month. 
